Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual Meeting of the American Association for the …

Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual Meeting of the American Association for the …
Salix Pharmaceuticals, Inc. today announced that the 61st Annual Meeting of the American Association for the Study of Liver Diseases will be an important venue for ongoing discussion of hepatic encephalopathy, or HE.
Read more on Business Wire via Yahoo! Finance

Conn. governor hopefuls say urban areas a priority
More opportunities for jobs and education reform will help jumpstart Connecticuts urban areas, the state’s gubernatorial candidates told an audience Friday night.
Read more on Seattle Times

FDA Approves Once-Daily LATUDA® (lurasidone HCL) for the Treatment of Patients with Schizophrenia
MARLBOROUGH, Mass.–(BUSINESS WIRE)–FDA approves LATUDA® (lurasidone HCl), a once-daily atypical antipsychotic for the treatment of patients with schizophrenia. LATUDA offers a treatment option to manage schizophrenia symptoms.
Read more on Business Wire